Inventurus Knowledge Solutions Limited has informed the Exchange about Investor Presentation

IKS Health, a healthcare enablement platform serving 700+ healthcare organizations, reported strong Q4 FY25 results with revenue of INR 7,240 mn (up 17% YoY in INR, 13% in USD) and adjusted EBITDA of INR 2,378 mn (up 72.5% YoY) at a 32.8% margin, up from 22.2% in Q4 FY24. For full year FY25, revenue grew 47% YoY in INR to INR 26,640 mn, with adjusted EBITDA margin expanding to 30.7% from 29.6% and adjusted PAT growing 38.9% YoY to INR 5,504 mn. The company announced three large platform deal wins (OrthoNY, GI Alliance, Sky Lakes, Western Washington Medical Group, Platinum Dermatology Partners) and continues strong cash generation with 55.6% FCF and 56.7% FCF yield. ROE stood at 29% with EPS up 30.6% YoY. The presentation also highlights a US$222bn TAM and 90%+ revenue from repeat customers.